Quality of Care and Quality Improvement

16: Artificial intelligence modelling to predict the risk of cardiotoxicity among renal cell carcinoma patients treated with vascular endothelial growth factor receptors tyrosine kinase inhibitors.

17: Kidney cancer clinical trials: a decision aid for patients and clinicians

18: Non-Index vs Index Readmissions Following Radical Nephrectomy: Causes, Costs, and Outcomes

19: Non-Index vs Index Readmissions Following Partial Nephrectomy: Causes, Costs, and Outcomes